Global Biologics CDMO Market Research Report 2022-2026: Growing Need to Focus on Core Competencies & Strong Research and Development Pipeline of Biologics Therapeutics - ResearchAndMarkets.com

The "Global Biologics CDMO Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.

The biologics CDMO market is poised to grow by $8.65 bn during 2022-2026, progressing at a CAGR of 12.20%

This study identifies the growing need to focus on core competencies as one of the prime reasons driving the biologics CDMO market growth during the next few years.

The market is driven by the availability of cost-efficient resources in emerging markets and strong research and development pipeline of biologics therapeutics.

The report on the biologics CDMO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The biologics CDMO market analysis includes the type segment and geographic landscape.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics CDMO market vendors that include AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., Fujifilm Diosynth Biotechnologies USA Inc., JRS PHARMA GmbH and Co. KG, Lonza Group Ltd., Rentschler Biopharma SE, Samsung BioLogics Co. Ltd., and WuXi Biologics (Cayman) Inc.

Also, the biologics CDMO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Key Topics Covered:

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2021
• Market outlook: Forecast for 2021 - 2026

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Mammalian - Market size and forecast 2021-2026
• Microbial - Market size and forecast 2021-2026
• Cell therapy services - Market size and forecast 2021-2026
• Market opportunity by Type

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2021-2026
• Europe - Market size and forecast 2021-2026
• Asia - Market size and forecast 2021-2026
• ROW - Market size and forecast 2021-2026
• Key leading countries
• Market opportunity By Geographical Landscape
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AGC Biologics
• Binex Co. Ltd.
• Boehringer Ingelheim International GmbH
• Catalent Inc.
• Fujifilm Diosynth Biotechnologies USA Inc.
• JRS PHARMA GmbH and Co. KG
• Lonza Group Ltd.
• Rentschler Biopharma SE
• Samsung BioLogics Co. Ltd.
• WuXi Biologics (Cayman) Inc.

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/f8b94a

View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005614/en/